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Diseases of the rich? The social patterning of hypertension in six low and middle income 
countries. 
 
Abstract: This paper identifies a general perception among development 
policymakers that health conditions such as hypertension and other non-
communicable diseases (NCDs) disproportionately affect privileged socioeconomic 
groups. The paper argues that this framing of the issue is derived more by 
established discourses and institutional dynamics than by evidence. The paper then 
assesses the validity of this view, with reference to the social patterning of 
hypertension in China, Ghana, India, Mexico, the Russian Federation and South 
Africa. Using data for adults aged 50+ from the WHO Survey of Ageing and Adult 
Health, it finds the social patterning of hypertension prevalence varies markedly 
between the study countries, but that hypertension awareness and control rates are 
generally lower for less advantaged groups. This reveals a need to challenge 
misleading representations of NCD pandemics and for interventions that specifically 
target the poor. 
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Introduction. 
Hypertension and non-communicable diseases (NCDs) are not as yet priority issues for 
international development. This is surprising, since NCDs already account for a higher share 
of mortality and illness in low and middle income countries (LMICs) than infectious diseases 
do, and are set to rapidly increase (WHO, 2010). Referring to the broader policy literature, 
the papers identifies reasons for this general neglect. These include a general perception 
that, in contrast to high income countries, in LMICs NCDs disproportionately affect relatively 
wealthy groups.  Drawing on survey data for six countries, we examine the validity of this 
perception with particular reference to hypertension prevalence, awareness and effective 
control.  In conclusion, we considers the wider applications of its findings for agenda-setting 
for NCDs in global health.  
 
NCDs, hypertension and international development priorities. 
NCDs include a range of health conditions, such as cardio-vascular diseases, cancers and 
diabetes.  In 2008 they accounted for 63 per cent of all deaths globally, and 80 per cent of 
these deaths occurred in LMICs (WHO, 2010). In all world regions except Africa the number 
of deaths caused by NCDs in 2008 already exceeded those caused by infectious, maternal, 
perinatal and nutritional diseases combined. It is projected that this will be the case for 
Africa by 2030 (WHO, 2010). NCDs also account for around half the global burden of illness 
and disability (Beaglehole et al, 2011). 
Hypertension is by some distance the leading risk factor for NCDs. WHO estimates that in 
2008 hypertension was responsible for about 13 per cent of all global deaths (WHO, 2010). 
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Uncontrolled hypertension is a key, potentially preventable and readily treatable, risk factor 
for many prevalent diseases including stroke, ischaemic heart disease, renal insufficiency 
and dementia (Steyn et al, 2005; Ferri et al, 2011). Hypertension itself shares risks factors 
(such as obesity and lack of exercise) with other conditions, such as diabetes. As such, 
hypertension can be taken as broadly indicative of a wider set of NCD health risks and illness 
outcomes. There are also associations between hypertension and some forms of highly 
active antiretroviral therapy for HIV/AIDS (Crane et al, 2006).  
Robust data on hypertension in LMICs are limited, due to a lack of emphasis on the 
epidemiological surveillance of NCDs (Banerjee, 2012). This is not helped by the 
asymptomatic nature of hypertension, which leads to low levels of awareness, reducing the 
reliability of data based on self-report, unless they are supported by diagnostic data. As 
such, estimates vary. Estimates from WHO and a Lancet meta-analysis both show rates of 
hypertension in developing regions now compare to those in high income ones (Kearney et 
al, 2005; WHO, 2010). According to the WHO study, Africa is the region with the highest 
estimated rates in the world -46 per cent for over 25s.i 
Despite growing evidence of the prominence of NCDs in LMICs, these health conditions 
continue to receive a low priority as a development issue (Beaglehole et al, 2011; De 
Maeseneer et al 2012). It has been estimated that NCDs accounted for only 3 per cent of 
total global health assistance between 2001 and 2008 (Nugent and Feigl, 2010). In 2008/9 
NCDs accounted for less than 4 per cent of health spending by the UK’s Department for 
International Development (DFID).  More than half of DFID’s health budget went to 
HIV/AIDS, TB and malaria: conditions it labels “killer diseases” (Jones and Young, 2007). In 
2011 a United Nations summit on NCDs proposed ten global targets, including a 25 per cent 
4 
 
relative reduction in hypertension, but no specific funds were set aside by member states to 
achieve these targets (NCD Alliance, 2012). This imbalance can also be seen at the country 
level, such as the lack of reference to NCDs in the health sections of poverty reduction 
strategy papers.  
Why are NCDs neglected, given the evidence of their rising prevalence? Social 
constructionist policy theory posits that the specific framing of policy issues and the nature 
of global policy communities can exert an equal or greater influence than objective, 
scientific evidence on priority-setting (Shiffman, 2009). Until recently, global institutional 
communities with particular interests in NCDs were weakly-articulated and uninfluential 
(Alleyne et al, 2013). More generally, global health agencies have remained focussed on 
historical health priorities, such as infectious disease, failing to respond to the changing 
epidemiology. At the same time, the NCD agenda has been resisted by powerful economic 
interests, such as global food alcohol and tobacco industries (Moodie et al, 2013).   
Equally, the framing of NCDs as a global development concern has faced numerous 
difficulties. Unlike pandemics of infectious diseases, NCDs are not usually viewed as 
threatening by the populations of high income countries. The term “NCD” is itself 
problematic, given its lack of recognition by the general public. Another key difficulty, of 
particular relevance to policy-makers in development agencies, is the perceived relationship 
between NCDs and poverty. A recent WHO report on NCDs observed that there is a 
persistent perception that NCDs primarily affect wealthier groups in LMICs (WHO, 2010). 
This perception is influenced by the wider notion of epidemiological transition (ET) away 
from so-called “diseases of poverty” (infectious and nutritional) to so-called “diseases of 
affluence” (including NCDs) (Omran, 2005). Although rates of many NCDs are higher in 
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poorer regions than richer ones, ET continues to frame global health thinking. This can be 
seen by a continued tendency within global health discourse to apply the label “diseases of 
poverty” to infectious conditions such as HIV/AIDS, TB and malaria. For example, a WHO 
report on health priorities for low income countries labelled infectious, nutritional and 
maternal conditions “poverty-related diseases”, and NCDs as “developed country diseases” 
(WHO, 2004a). Whilst the report does make the point that NCDs are accounting for a 
growing share of mortality and illness in LMICs, this labelling implies that the poorest groups 
within these countries are relatively unaffected by NCDs.  This is an entrenched view which 
the authors have frequently encountered among influential development policy-makers.  
Epidemiological research demonstrating strong associations between being overweight or 
obese and the risk of many NCDs feeds into this view, albeit based on an assumption that 
being overweight does not occur among poorer groups (Neuman et al, 2011). At the same 
time, it is widely claimed that NCDs are strongly associated with urbanisation and 
population ageing (WHO 2010, Yach et al, 2004). This suggests that NCDs are relatively 
unimportant for rural populations and younger age groups, who tend to be prioritised in 
development policy.  More generally, the evidence to support the view that NCDs 
disproportionately affect richer, more privileged socio-economic strata is not as robust or as 
consistent as these claims imply. In high income countries like the UK, there is a clear social 
gradient whereby lower socio-economic status is clearly associated with a higher risk of 
hypertension (Hotchkiss et al, 2011; Singh-Manoux et al, 2008). There is also evidence from 
the UK that levels of hypertension awareness (and hence control) tend to be lower for 
poorer groups (Johnston et al, 2009). Historical records for developed countries show a 
reversal of the social health gradient as a result of growing prosperity and changed lifestyles 
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(Chan et al, 2002). This involved a shift in NCD patterns from conditions that 
disproportionately affected the rich, to disproportionately affecting the poor.  
The question is whether developing countries will follow the same trend and at what point 
this will occur, but the limited available evidence does not provide a conclusive answer 
(Gwatkin, 2013; Subramanian et al, 2013; Di Cesare et al, 2013). Current knowledge about 
where “tipping points” are likely to occur in the social gradient of health remains limited 
(Suhrcke et al, 2006).  The few available studies of hypertension gradients in LMICs produce 
divergent results. For example, a study from Cuba showed that higher levels of education 
were associated with higher rates of hypertension for men but lower rates for women 
(Ordunez et al, 2005). A separate study in India found hypertension was significantly more 
prevalent in lower education groups for both men and women (Reddy et al, 2007), and 
similar results were reported for rural Uganda (Murphy et al, 2014). There is no evidence on 
levels of awareness or control of hypertension across socio-economic strata in LMICs. This is 
an important knowledge gap –if rates of control are lower for the poor, their exposure to 
stroke and other health risks will be higher than for other groups with equivalent rates of 
hypertension prevalence. 
Similarly, there is only limited evidence to evaluate the claim that NCDs disproportionately 
affect urban populations. In fact, recent surveys of mortality and illness among rural 
populations in LMICs report higher than expected rates of NCDs (Joshi et al, 2006; Kahn et al 
2006). Whilst age is a risk factor for hypertension and most NCDs, data for developed 
countries show large variations in age-specific rates, indicating a large degree of elasticity in 
the relationship between chronological age and risk (WHO, 2004b).    
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Despite the growing body of evidence that suggests otherwise, perceived associations of 
NCDs with developed countries (or groups within LMICs who enjoy developed country 
lifestyles) partly explains the continued low priority given to these conditions as a 
development issue (Beaglehole et al, 2011; De Maeseneer et al 2012). Consequently, there 
is a clear need to strengthen the evidence base to challenge this framing. The next sections 
of this paper review evidence for overall rates of hypertension in six LMICs, paying particular 
attention to social gradients and rural/urban disparities. As well as the prevalence of 
hypertension, they consider levels of awareness, control and treatment effectiveness.  
 
Data and methods. 
We used new data from the World Health Organization Study on Global Aging and Adult 
Health (SAGE).  This comprises nationally representative household surveys in six countries, 
China, Ghana, India, Mexico, South Africa and the Russian Federation. Sampling methods 
were based on the design developed for the World Health Survey (WHS, 2003) where a 
probability sampling design was employed using multi-stage, stratified, random cluster 
samples. The primary sampling units were stratified by region and location (urban/rural) 
and, within each stratum, enumeration areas were selected. Details are available at Kowal 
et al (2012) and the SAGE website (www.who.int/healthinfo/systems/sage).  The six 
countries comprise a total study population of 35,125 people aged 50 and over. Table 1 
shows the distribution of characteristics for the SAGE sample as a whole and by country and 
response rates. With the exception of Mexico, individual response rates ranged from 92.3 
per cent in India to 77.7 per cent in South Africa. The response rate for Mexico was only 
52.4 per cent, calling into question the robustness of the data for this country.  
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TABLE 1 ABOUT HERE 
 
The SAGE data analysis was weighted, reflecting the inverse of the probability of selection 
for each individual, trimmed and post-stratified, based on the UN Population Standards 
data. The SAGE protocol required three objective blood pressure measurements; a self-
reported question (have you ever been diagnosed with high blood pressure?); and two 
treatment question (have you been taking any medications or other treatment during the 
last two weeks?; have you been taking any medications or other treatment during the last 
12 months?).ii The period of data collection varied by country, ranging from 2007 to 2010.  
 
We used a multivariable logistic regression to examine the association of a range of 
characteristics with the following outcomes: hypertension, awareness of diagnosis and use 
of anti-hypertensives. This was applied to each country sample individually, and to the total 
pooled sample. All characteristics were retained in the final "forced" multivariable model, 
with complete data on all variables. Hypertension was defined if the mean of the last two 
measurements was ≥140 (Systolic blood pressure) or ≥90 (Diastolic blood pressure), or by 
currently taking anti-hypertensives. Control of hypertension was defined as being on 
treatment during the previous two weeks and a mean blood pressure below 140/90 over 
the previous two measurements. A person was defined as aware if he/she was hypertensive 
and self-reported the condition. Thus, the proportion of controlled hypertension included 
those who self-reported being hypertensive and on treatment among all those who were 
hypertensive or normotensive on treatment. The proportion of effective treatment included 
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those who were on treatment and were normotensive among all hypertensives on 
treatment.  
 
Independent variables were chosen from characteristics previously associated with 
hypertension in the literature.  For the hypertension analysis, the adjusted model included: 
age, sex, education, wealth quintiles at the household level, location (rural/urban), body 
mass index (BMI, kg/m2), smoking, alcohol consumption and physical exercise. Body Mass 
Index (BMI) was classified as follows: underweight: BMI<18.5; normal: 18.5≤BMI<25; 
overweight: 25 ≤BMI<30; obese: BMI≥30. Wealth quintiles were derived from the household 
ownership of durable goods, dwelling characteristics (type of floors, walls and cooking 
stove), and access to services (improved water, sanitation and cooking fuel) for a total of 21 
assets. Household economic status was determined using a dichotomous hierarchical 
ordered probit model, based on ownership of these selected assets and access to certain 
services (Ferguson et al, 2003;  Gakidou et al, 2007; Hosseinpoor et al, 2005). This model 
returns a summary index between 0 (low ownership/access) and 1 (high), whose quintiles 
are entered into the logistic regression as a covariate. Goodness-of-fit was assessed through 
the global chi-square, the Hosmer-Lemeshow statistics, the area under the ROC, the 
Pearson residual and the variance residual, and by plotting the estimated values versus 
residuals. Assessment of collinearity was checked by computing the tolerance and variance 
inflation factor produced by the linear regression analysis.  
We applied similar models to participants observed to have hypertension or anti-
hypertensive treatment to determine the factors associated with awareness, control and 
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treatment efficacy.  The adjusted model included: age, sex, education, location (rural/urban) 
and household wealth quintiles.  
 
Social gradients of hypertension prevalence, awareness and control.  
TABLE 2 ABOUT HERE 
Table 2 shows the prevalence of hypertension across the six SAGE countries, as well as by 
wealth quintile, rural/urban location and level of education. Although there are variations 
between wealth and education categories, the cross-national differences are much larger. 
Overall prevalence ranged from 33 per cent in India to 78 per cent in South Africa; 
comparable to rates reported for high income countries (Egan et al, 2010). The prevalence 
of hypertension in South Africa is the highest that has ever been recorded by a nationally 
representative study for any country in the world. South Africa is the only country in 
southern Africa for which these data are available, raising the question whether 
neighbouring countries may have similar or even higher rates of prevalence. There is no 
apparent relationship between levels of national economic development and prevalence, 
with similar rates reported for Ghana, Mexico and China. 
Table 2 does not show consistent patterns of social gradients by wealth quintile. In the case 
of India and Ghana, there is higher prevalence among wealthier groups, while in China and 
the Russian Federation, there are below average rates of prevalence for the wealthiest 
quintile. In South Africa there is no indication of a gradient either way. Mexico displays an 
unusual pattern, with particularly high rates for quintile 2, although this may be an artefact 
of low response rates and so should be treated with some caution. Comparisons across 
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education groups need to take into account that the numbers in some categories are very 
small: for example, only 10.5 per cent of older people in Mexico had higher education and 
only 0.7 per cent of older Russians had no education. India and Ghana show a slight gradient 
towards higher prevalence among more educated groups. Conversely, China, the Russian 
Federation, South Africa and Mexico show lower rates for more educated groups. Taken 
together, the data on wealth quintiles and education suggest that India and Ghana have yet 
to pass any tipping point in the NCD social gradient, whereas China and the Russian 
Federation have done so. That said, rates of prevalence among the poorest and least 
educated in Ghana and India are only marginally below national averages, and so the 
significance of social gradients should not be over-stated. Relative rates of hypertension 
between rural and urban populations varied across the SAGE countries, with higher rates 
among rural older people in three cases (Mexico, China and South Africa).  
 
TABLE 3 ABOUT HERE 
Table 3 presents adjusted individual-level multivariable analysis of socio-economic 
characteristics potentially associated with hypertension.iii In India, prevalence was 
associated with the wealthiest quintile, as well as for quintile 4, but there were no 
significant associations for education. In Ghana, there were significant associations for 
quintiles three, four and five and for no education. This supports the hypothesis that India 
and Ghana have yet to pass any social gradient tipping point. South Africa presents a more 
varied scenario: there was a significant positive association with the wealthiest quintile, but 
there was a negative association with having a higher education. In China there were no 
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significant associations by either wealth quintile or education. In Mexico there was a 
significant positive association with quintile two and in Russia for quintile four. Rural 
location was positively associated in China, but negatively in Ghana. Female sex was 
positively associated in Ghana, India and South Africa. Being in older age groups was 
consistently associated with hypertension across the SAGE countries, with the exception of 
Ghana where it was only significant for people aged 65 to 69.  
Taken together, the results in Table 3 indicate that India and Ghana have clear social 
gradients, with higher rates of hypertension among wealthier groups. The findings for the 
other four countries provide less persuasive evidence of a social gradient. In the case of 
South Africa, and to some extent Russia, this is probably in part because the rates of 
hypertension prevalence are very high for the population in general. It is also possible that 
these countries, along with China, have reached a social gradient tipping point, leading to 
less linear sets of associations.  
 TABLE 4 ABOUT HERE 
Separate epidemiological analysis of non-socio-economic risk factors for hypertension in the 
same populations reports a very strong, significant and consistent association with higher 
body mass index (BMI) (Lloyd-Sherlock et al, 2014). Given this strong association, it is of 
interest to assess the socio-economic patterning of high BMI.  Table 4 shows data on the 
prevalence of overweight/obesity for the SAGE countries and again reveals much larger 
variations between countries than across social groups. Overall rates of overweight/obesity 
ranged from 12.9 per cent in India to 78.0 per cent in Mexico. Rates of obesity were higher 
for wealthier quintiles in five countries; in the case of the Russian Federation, there was less 
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evidence of a social gradient.  In three countries (Mexico, South Africa and the Russian 
Federation) obesity was a generalised condition and, although rates were higher for the 
wealthy, over 60 per cent of the poorest quintile was overweight/obese. In the other three 
(India, Ghana and China) overall rates were much lower and there was a much more notable 
social gradient. In the case of India, rates for the wealthiest quintile (25.5 per cent) were 
more than eight times those for the poorest (3.2 per cent). In India, Ghana and China, the 
social gradient for obesity was more pronounced than the one for hypertension, indicating 
that the relationship between high BMI, as well as other risk factors and hypertension may 
vary across socio-economic groups. The differences in overall rates and social gradients 
between these two sets of countries largely reflect their current positions in the nutritional 
transition (Prentice, 2006).  
TABLE 5 ABOUT HERE 
 
Table 5 shows the proportion of people with hypertension who were aware of their 
condition. As with prevalence, there are large national variations with awareness ranging 
from 72 per cent in the Russian Federation to 23 per cent in Ghana. There are clear social 
gradients by wealth quintile for all countries other than Mexico, where awareness is 
particularly low for quintile 2.  For education, there are gradients for India and Ghana and 
less consistent patterns for the other countries. The effects of rural/urban location varied by 
country. In China, Ghana, India and South Africa, rural populations had lower awareness, 
whereas in Mexico and Russia they were higher.   
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TABLE 6 ABOUT HERE 
Table 6 presents the findings of the multivariable analysis of socio-economic effects on 
awareness. Being in wealth quintiles two, three, four and five was positively associated with 
awareness in China and in India. For Ghana, there were significant associations for quintiles 
three four and five and in Russia just for quintile five. There were fewer significant results 
for education. In Ghana having no education was negatively associated with awareness and 
higher education was positively associated. In India higher education was also associated 
with awareness. In Russia there was a negative association for no education, but the 
number in this category was very small. Female sex was positively associated in every 
country other than Mexico. Rural location was negatively associated with awareness in all 
countries other than Mexico and Russia. Taken together, the results presented in Table 6 
demonstrate clear social gradients for awareness in China, Ghana and India, whereby being 
less wealthy and living in rural locations was associated with lower levels of awareness.   
 
TABLE 7 ABOUT HERE 
 
Table 7 shows the proportion of people who were hypertensive but who had their condition 
under control due to effective treatment. National rates of control are low, ranging from 4.1 
per cent in Ghana to 14.1 per cent in India. All countries other than Mexico demonstrate 
pronounced social gradients, with lower rates of control among the poor. There are clear 
gradients for education groups in India, China and the Russian Federation, but less 
15 
 
consistent patterns for the other three countries. Control rates are lower in rural locations 
for all countries other than Mexico, where they are higher.  
 
TABLE 8 ABOUT HERE 
Table 8 presents the multivariate analysis for determinants of hypertension control. Being in 
wealth quintiles four and five was positively associated with control in India and Russia, as 
was being in quintile five in Ghana. Having secondary or higher education was associated 
with control in China, and higher education was also significant in India. By contrast, having 
no education was associated with lower rates of control in Russia. In all countries other than 
Mexico and South Africa rural location was negatively associated with control. In India and 
South Africa, female sex was associated with higher rates. 
Taken together, the descriptive and multivariate analyses in Tables 2 to 8 show considerable 
variation in national experience. Ghana and India present a clear prevalence gradient with 
higher rates of hypertension among wealthier groups. However, these effects are to some 
extent off-set by higher rates of awareness and control among these groups. There were 
less consistent results for the other SAGE countries, or for educational categories.  
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Conclusions. 
This paper demonstrates a strong perception in the international development community 
that NCDs are conditions associated with affluence and therefore are inherently less 
important than health conditions supposedly associated with poverty. Whilst not always 
expressed explicitly, this view is manifested in the almost complete neglect of NCDs by the 
main academic journals related to international development. This paper contributes to the 
growing evidence that this perception is almost entirely unfounded. While it is true that the 
prevalence of hypertension is higher for wealthier groups in Ghana and India, this does not 
mean it is uncommon among the poor. In the case of Ghana, nearly half the poorest quintile 
were found to be hypertensive. Moreover, it is essential to go beyond prevalence data to 
consider the extent to which individuals are able to effectively manage these conditions. 
With the exception of Mexico, the SAGE data show that poorer, less educated groups and 
those in rural areas are less likely to be aware they have hypertension or to be effectively 
controlling their condition. This indicates the need for tailored interventions to meet the 
needs of these groups in low and middle income countries, drawing on wider experiences of 
extending basic health services to excluded groups.  
There is a tendency to frame the growing prevalence of NCDs as an almost inevitable 
epidemic of wider global trends such as population ageing, urbanisation and modernisation. 
However, the SAGE data show an inconsistent association between urban location and 
prevalence, coupled with high rates of awareness and control in urban locations. Better 
access to healthcare among the urban population has a positive effect on controlling 
hypertension and may be a benefit of urbanisation. Similarly, the data show large variations 
in prevalence between countries for the same age groups, indicating that the effect of 
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population ageing on NCDs is far from inevitable and inelastic. This calls into question a 
tendency to exclude older people from NCD interventions (Lloyd-Sherlock et al, 2015). 
The evidence that NCDs matter for poor people in poor countries is increasingly abundant. 
However, this evidence alone may not be enough to overcome the powerful institutional 
forces and discourses that continue to frame NCDs as something else. There are signs that 
global NCD networks are starting to gain influence, reflected in the inclusion of an NCD 
target in the Sustainable Development Goals. For now, rather than prove that NCDs affect 
the poor, the key challenge for researchers is to identify what works best in tackling these 
conditions among rural, uneducated and disadvantaged populations. Here the evidence 
remains minimal. 
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Table 1: Distribution (%) of characteristics, overall and by country. 
  China 
(n=13349) 
Ghana 
(n=4725) 
India 
(n=7150) 
Mexico 
(n=2315) 
Russian 
Federation 
(n=3763) 
South Africa 
(n=3839) 
Age (years) 
 
 
 
 
[50-54) 
[55-59) 
[60-64) 
[65-69) 
[70-74) 
[75+ 
21.8 
23.3 
17.2 
14.6 
11.1 
12.1 
21.0 
19.4 
14.8 
12.5 
14.3 
18.0 
23.6 
25.3 
16.5 
14.0 
10.6 
10.0 
26.3 
21.8 
14.3 
11.2 
7.8 
18.6 
23.1 
22.1 
11.5 
13.1 
10.4 
19.8 
28.3 
21.5 
16.9 
13.7 
8.4 
11.2 
Sex 
 
Males 
Females 
49.8 
50.2 
49.7 
50.3 
51.1 
48.9 
46.8 
53.2 
38.9 
61.1 
44.0 
56.0 
25 
 
Education  
 
 
 
None  
Primary 
Secondary 
Higher 
23.8 
39.5 
19.7 
17.0 
54.0 
21.3 
4.0 
20.7 
51.2 
24.9 
10.2 
13.7 
17.2 
62.4 
9.9 
10.5 
0.7 
6.8 
20.2 
72.3 
25.2 
46.4 
14.2 
14.2 
BMI 
 
 
 
Normal 
Underweight 
Overweight 
Obese 
60.5 
4.3 
29.5 
5.7 
55.3 
15.3 
19.7 
9.7 
48.3 
39.0 
10.6 
2.1 
21.4 
0.6 
49.4 
28.6 
23.8 
1.1 
40.8 
34.3 
24.7 
3.3 
26.9 
45.1 
Location 
 
Urban 
Rural 
47.6 
52.4 
40.6 
59.4 
29.4 
70.6 
78.8 
21.2 
72.7 
27.3 
64.9 
35.1 
Wealth 
quintile 
Poorest 
Q2 
16.3 
18.2 
18.4 
19.4 
17.9 
19.3 
15.3 
24.7 
16.2 
19.6 
20.7 
19.9 
26 
 
 
 
 
Q3 
Q4 
Richest 
20.5 
23.3 
21.7 
20.7 
20.0 
21.5 
18.8 
19.5 
24.5 
16.8 
16.6 
26.6 
19.1 
20.5 
24.6 
18.2 
19.8 
21.4 
Response rate  92.3 78.4 87.3 52.4 82.3 77.7 
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Table 2. Prevalence of hypertension by wealth quintile, education and living area (% of total population aged 50 and over). 
 China Ghana India Mexico Russia S Africa 
Overall 59.5 57.1 32.6 58.2 71.1 77.9 
Poorest quintile 62.7 47.1 25.9 63.8 72.3 76.0 
Quintile 2 58.6 52.8 30.2 71.3 74.7 76.8 
Quintile 3 59.8 56.6 30.1 46.9 74.0 78.5 
Quintile 4 60.0 61.7 34.0 53.9 75.3 78.3 
Wealthiest quintile 56.7 65.6 40.4 51.9 61.4 79.2 
No education 64.4 54.3 31.1 75.6 81.3 80.7 
Primary 60.1 60.6 33.3 57.4 87.8 79.4 
Secondary 57.0 58.0 33.4 41.9 76.5 78.7 
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Higher 53.9 61.2 35.9 49.9 67.9 72.7 
Urban 57.0 65.7 37.0 57.5 71.1 77.7 
Rural 61.6 51.2 30.8 60.9 71.0 78.2 
 
29 
 
Table 3. Odds ratios (95% CI) for hypertension (adjusted for all the other variables in the table). 
  China 
(n=11980) 
Ghana 
(n=3931) 
India 
(n=4420) 
Mexico 
(n=2060) 
Russian Federation 
(n=3200) 
South Africa 
(n=2610) 
        
Age (years) [50-54) 
[55-59) 
[60-64) 
[65-69) 
[70-74) 
[75+ 
1 
1.32 (1.19-1.48) 
1.78 (1.59-2.00) 
2.22 (1.86-2.64) 
2.73 (2.24-3.34) 
3.23 (2.68-3.89) 
1 
1.08 (0.85-1.38) 
1.19 (0.91-1.54) 
1.36 (1.04-1.78) 
1.20 (0.92-1.58) 
1.09 (0.84-1.40) 
1 
1.31 (0.99-1.74) 
1.16 (0.88-1.52) 
1.78 (1.30-2.44) 
1.83 (1.37-2.46) 
1.89 (1.43-2.51) 
1 
1.83 (0.82-4.10) 
2.74 (1.21-6.24) 
5.21 (2.45-11.09) 
5.17 (2.65-10.06) 
4.80 (2.30-10.05) 
1 
1.42 (0.81-2.48) 
2.20 (1.27-3.83) 
1.88 (0.80-4.41) 
3.08  (1.69-5.61) 
4.60 (2.51-8.44) 
1 
1.36 (0.93-1.98) 
1.58 (0.99-2.54) 
1.52 (1.03-2.26) 
1.38 (0.79-2.41) 
1.62 (1.09-2.40) 
        
Sex Males 
Females 
1 
1.05 (0.97-1.13) 
1 
1.31 (1.12-1.54) 
1 
1.38 (1.16-1.63) 
1 
1.22 (0.71-2.12) 
1 
1.31 (0.86-2.00) 
1 
1.42 (1.09-1.85) 
        
Education Primary 
None 
Secondary 
1 
0.95 (0.80-1.13) 
1.07 (0.96-1.19) 
1 
0.80 (0.66-0.98) 
0.77 (0.51-1.16) 
1 
0.90 (0.73-1.10) 
1.07 (0.83-1.38) 
1 
2.12 (0.98-4.60) 
0.61 (0.26-1.44) 
1 
0.55 (0.19-1.60) 
0.65 (0.33-1.27) 
1 
1.09 (0.81-1.48) 
0.86 (0.57-1.28) 
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Higher 0.90 (0.75-1.07) 0.94 (0.74-1.19) 1.10 (0.85-1.43) 0.73 (0.32-1.66) 0.65 (0.38-1.12) 0.59 (0.39-0.90) 
        
Location Urban 
Rural 
1 
1.38 (1.19-1.61) 
1 
0.64 (0.52-0.79) 
1 
0.87 (0.68-1.11) 
1 
0.95 (0.45-1.99) 
1 
1.12 (0.71-1.76) 
1 
1.00 (0.71-1.40) 
        
Wealth quintile Poorest 
Q2 
Q3 
Q4 
Richest 
1 
0.94 (0.80-1.09) 
1.06 (0.92-1.22) 
1.17 (0.99-1.37) 
1.14 (0.94-1.37) 
1 
1.20 (0.99-1.46) 
1.36 (1.06-1.74) 
1.55 (1.19-2.01) 
1.68 (1.28-2.21) 
1 
1.25 (0.89-1.76) 
1.22 (0.94-1.56) 
1.47 (1.15-1.86) 
1.78 (1.38-2.29) 
1 
2.65 (1.07-6.56) 
0.92 (0.44-1.95) 
1.29 (0.67-2.46) 
1.52 (0.79-2.92) 
1 
1.16 (0.81-1.67) 
1.07 (0.60-1.90) 
1.58 (1.05-2.39) 
0.86 (0.53-1.39) 
1 
1.00 (0.62-1.62) 
1.24 (0.76-2.04) 
1.43 (0.88-2.33) 
1.80 (1.04-3.12) 
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Table 4. Prevalence of overweight/obese by wealth quintile, education and living area (% of total population aged 50 and over). 
 China Ghana India Mexico Russia S Africa 
Overall 35.2 29.5 12.8 78.0 75.1 72.1 
Poorest quintile 23.8 12.2 2.9 69.3 72.4 60.2 
Quintile 2 30.1 19.5 8.8 76.8 72.8 64.6 
Quintile 3 36.0 22.8 10.7 79.1 70.3 74.0 
Quintile 4 39.9 37.6 12.0 82.0 82.1 81.1 
Wealthiest quintile 42.0 51.1 25.7 80.9 76.2 80.6 
No education 31.9 24.3 8.2 72.3 94.9 60.9 
Primary 34.9 32.2 14.3 79.9 60.4 70.9 
Secondary 37.0 44.3 17.8 75.0 75.2 83.5 
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Higher 38.4 36.9 22.9 82.3 76.2 80.8 
Urban 39.4 44.1 22.0 79.5 74.8 76.5 
Rural 31.6 19.3 9.1 72.9 75.8 64.1 
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Table 5. Prevalence of hypertension awareness by wealth quintile, education and living area (% of people with hypertension). 
 China Ghana India Mexico Russia S Africa 
Overall 42.7 23.3 37.8 44.6 72.1 38.0 
Poorest quintile 34.1 11.0 18.6 52.5 63.6 28.2 
Quintile 2 38.1 13.5 32.8 29.1 72.5 34.1 
Quintile 3 42.7 18.0 34.5 51.2 72.9 39.8 
Quintile 4 45.0 28.9 38.1 51.7 68.5 42.6 
Wealthiest quintile 51.9 37.5 52.5 51.3 81.7 44.0 
No education 40.8 17.9 30.4 42.7 90.0 34.8 
Primary 38.2 23.7 35.8 43.6 67.6 40.5 
Secondary 45.1 32.7 44.9 38.3 76.7 39.8 
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Higher 56.1 33.7 60.0 61.0 70.8 33.7 
Urban 57.0 32.7 51.5 42.8 71.7 40.8 
Rural 31.4 15.0 31.4 50.6 73.2 32.9 
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Table 6. Adjusted model for being aware of the presence of hypertension by country (Odds Ratios with 95% Confidence Intervals). 
  China 
(n=3565) 
Ghana 
(n=1510) 
India 
(n=1798) 
Mexico 
(n=454) 
Russian Federation 
(n=1495) 
South Africa 
(n=1165) 
Wealth quintile Poorest 
Q2 
Q3 
Q4 
Richest 
1 
1.20 (1.03-1.40) 
1.30 (1.07-1.58) 
1.39 (1.20-1.60) 
1.42 (1.14-1.76) 
1 
1.16 (0.71-1.88) 
1.55 (0.99-2.42) 
2.49 (1.64-3.80) 
3.22 (2.03-5.08) 
1 
2.02 (1.20-3.40) 
1.92 (1.10-3.36) 
2.14 (1.32-3.47) 
2.67 (1.61-4.44) 
1 
0.44 (0.17-1.13) 
1.00 (0.51-1.97) 
1.13 (0.54-2.37) 
1.16 (0.53-2.57) 
1 
1.66 (0.97-2.82) 
1.70 (0.96-3.03) 
1.57 (0.80-3.07) 
3.54 (1.49-8.41) 
1 
1.12 (0.66-1.88) 
1.37 (0.82-2.27) 
1.42 (0.82-2.46) 
1.71 (0.96-3.03) 
Age (years)  1.03 (1.02-1.04) 1.03 (1.01-1.04) 1.02 (1.01-1.03) 1.04 (1.01-1.06) 1.02 (0.99-1.04) 1.03 (1.02-1.05) 
sex Males 
Females 
1 
1.47 (1.34-1.61) 
1 
2.27 (1.74-2.97) 
1 
1.96 (1.43-2.68) 
1 
1.68 (0.97-2.89) 
1 
2.44 (1.60-3.72) 
1 
1.58 (1.16-2.14) 
Location Urban 
Rural 
1 
0.44 (0.38-0.51) 
1 
0.54 (0.40-0.74) 
1 
0.61 (0.46-0.83) 
1 
1.37 (0.73-2.57) 
1 
1.03 (0.53-2.00) 
1 
0.68 (0.49-0.94) 
Education Primary 
None 
Secondary 
Higher 
1 
0.97 (0.85-1.13) 
1.18 (0.99-1.42) 
1.43 (1.20-1.70) 
1 
0.66 (0.46-0.93) 
1.31 (0.68-2.53) 
1.53 (1.05-2.23) 
1 
0.79 (0.55-1.13) 
1.64 (0.99-2.69) 
2.87 (1.67-4.96) 
1 
0.96 (0.44-2.07) 
0.89 (0.39-2.06) 
2.02 (0.68-6.03) 
1 
3.85 (1.07-13.89) 
1.70 (0.74-3.95) 
1.40 (0.55-3.55) 
1 
0.84 (0.62-1.14) 
0.88 (0.58-1.33) 
0.69 (0.41-1.15) 
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Table 7. Prevalence of hypertension control by wealth quintile, education and living area (% of people with hypertension). 
 China Ghana India Mexico Russia S Africa 
Overall 8.3 4.1 14.1 11.8 10.5 7.8 
Poorest quintile 4.9 1.7 5.4 15.7 5.8 3.0 
Quintile 2 6.5 1.4 7.6 5.4 9.2 6.8 
Quintile 3 8.7 2.0 9.3 14.2 10.1 6.5 
Quintile 4 9.7 3.7 17.0 17.0 11.9 11.6 
Wealthiest quintile 11.0 9.9 23.5 12.6 14.4 10.6 
No education 5.6 3.0 11.2 15.0 1.6 8.1 
Primary 6.2 4.0 13.1 10.4 10.7 6.8 
Secondary 10.2 9.4 17.8 11.2 10.3 10.1 
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Higher 16.5 5.8 22.8 13.3 10.6 7.2 
Urban 15.6 7.1 21.0 10.1 11.9 9.4 
Rural 2.5 1.5 10.9 17.3 6.7 4.8 
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Table 8. Adjusted model for effective control of hypertension in hypertensive participants (Odds Ratios with 95% Confidence Intervals). 
  China 
(n=3575) 
Ghana 
(n=1510) 
India 
(n=1802) 
Mexico 
(n=454) 
Russian 
Federation 
(n=1495) 
South Africa 
(n=1165) 
Wealth quintile Poorest 
Q2 
Q3 
Q4 
Richest 
1 
1.18 (0.74-1.86) 
1.18 (0.77-1.82) 
1.20 (0.78-1.83) 
0.93 (0.54-1.57) 
1 
0.71 (0.22-2.25) 
0.96 (0.28-3.34) 
1.44 (0.57-3.61) 
3.44 (1.44-8.17) 
1 
1.44 (0.60-3.43) 
1.65 (0.76-3.58) 
3.27 (1.55-6.90) 
3.98 (1.87-8.46) 
1 
0.45 (0.15-1.36) 
1.23 (0.48-3.16) 
1.85 (0.67-5.06) 
1.45 (0.38-5.55) 
1 
1.55 (0.77-3.11) 
1.87 (0.98-3.56) 
2.63 (1.45-4.76) 
3.34 (1.85-6.06) 
1 
2.29 (0.66-8.03) 
1.74 (0.58-5.17) 
2.60 (0.84-8.04) 
3.22 (0.98-10.56) 
Age (years)  1.01 (1.00-1.02) 1.03 (1.01-1.05) 1.02 (1.00-1.04) 1.02 (0.99-1.06) 1.01 (0.99-1.04) 1.02 (1.00-1.04) 
sex Males 
Females 
1 
0.99 (0.83-1.19) 
1 
1.38 (0.78-2.47) 
1 
1.59 (1.13-2.22) 
1 
3.06 (1.58-5.94) 
1 
1.44 (0.92-2.27) 
1 
1.74 (1.03-2.94) 
Location Urban 
Rural 
1 
0.16 (0.11-0.23) 
1 
0.33 (0.16-0.68) 
1 
0.67 (0.42-1.06) 
1 
1.84 (0.81-4.19) 
1 
0.49 (0.24-0.99) 
1 
0.64 (0.36-1.14) 
Education Primary 
None 
Secondary 
1 
0.98 (0.68-1.41) 
1.26 (0.99-1.59) 
1 
0.78 (0.36-1.71) 
1.58 (0.59-4.18) 
1 
1.01 (0.69-1.48) 
1.45 (0.84-2.51) 
1 
1.59 (0.75-3.38) 
1.40 (0.56-3.48) 
1 
0.12 (0.02-0.72) 
0.99 (0.52-1.91) 
1 
1.41 (0.76-2.60) 
1.30 (0.72-2.36) 
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Higher 1.62 (1.20-2.19) 1.05 (0.51-2.18) 1.77 (1.04-3.01) 1.44 (0.53-3.93) 0.99 (0.51-1.92) 0.87 (0.47-1.62) 
 
                                                          
i Attempts to isolate this a racial effect in comparative studies have been hampered by associations between race and socio-economic status (Ferdinand and Townsend, 
2012). 
ii Some studies indicate that the use of a single measurement occasion for defining hypertension may reduce the reliability of prevalence data, but it unlikely to affect the 
social gradients or associations with different population groups (Chiolero et al, 2007). 
iii Table 3 does not include other risk factors, such as weight or diet, since it is primarily concerned with social gradients and not a comprehensive analysis of potential risk 
factors. See Lloyd-Sherlock et al (2014) for a comprehensive, epidemiological analysis. 
